Ascend Laboratories LLC is recalling 4,728 bottles of Minocycline Hydrochloride Extended-Release Tablets (105 mg), a prescription antibiotic used to treat various infections. The recall was initiated because the tablets failed dissolution testing, which means the medication may not dissolve at the correct rate to be properly absorbed by the body. This issue was identified during routine quality testing. Consumers should contact their healthcare provider or pharmacist for guidance regarding their treatment and return any remaining medication to their pharmacy.
The tablets failed to meet the required dissolution specifications, which could lead to lower-than-intended levels of the medication being absorbed into the bloodstream. This may result in the medication being less effective at treating the underlying infection.
Healthcare consultation and product return.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.